M&A Activities in Pharmaceuticals – On rise
The acceleration in global pharmaceutical M&A activities in the first quarter of 2015 was driven by the intense competition among the companies to discover blockbuster drugs.
M&A activities
The acceleration in global pharmaceutical M&A activities in the first quarter of 2015 was driven by the intense competition among the companies to discover blockbuster drugs.
